Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1W15D | ISIN: US00182C1036 | Ticker-Symbol: BSFA
Tradegate
06.06.25 | 10:17
53,00 Euro
-2,75 % -1,50
1-Jahres-Chart
ANI PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
ANI PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
54,0055,0006.06.
54,0054,5006.06.

Aktuelle News zur ANI PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiANI Pharmaceuticals auf Jefferies-Konferenz: Strategisches Wachstum bei seltenen Krankheiten3
MiANI PHARMACEUTICALS INC - 8-K, Current Report2
23.05.ANI Pharmaceuticals erweitert Aktienpläne und Aktienanzahl5
22.05.ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin Gel for the Treatment of Acute Gout Flares96Purified Cortrophin Gel is the only ACTH therapy approved by the FDA for the treatment of acute gout flares Trial to be conducted by Dr. Hyon Choi at Massachusetts General Hospital and will compare...
► Artikel lesen
20.05.ANI PHARMACEUTICALS INC - 8-K, Current Report7
09.05.Cortrophin Demand Is Soaring For ANI Pharma, CEO Says Well-Positioned To Mitigate Potential Tariff Impact3
09.05.ANI Pharmaceuticals raises 2025 revenue guidance to $768M-$793M with 25%-29% growth3
09.05.ANI Pharma Q1 Profit Down, Revenues Rise; Raises FY25 Outlook; Stock Up In Pre-market - Update3
ANI PHARMACEUTICALS Aktie jetzt für 0€ handeln
09.05.ANI Pharmaceuticals, Inc. Q1 Profit Decreases, But Beats Estimates259WASHINGTON (dpa-AFX) - ANI Pharmaceuticals, Inc. (ANIP) reported earnings for first quarter that decreased from the same period last year but beat the Street estimates.The company's bottom line...
► Artikel lesen
09.05.ANI Pharmaceuticals Non-GAAP EPS of $1.70 beats by $0.32, revenue of $197.12M beats by $16.43M4
09.05.ANI PHARMACEUTICALS INC - 10-Q, Quarterly Report1
09.05.ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance988Generated record quarterly net revenues of $197.1 million, representing year-over-year growth of 43.4%Total Rare Disease quarterly net revenues of $69.0 million, which includes:Purified Cortrophin®...
► Artikel lesen
08.05.ANI Pharmaceuticals Q1 2025 Earnings Preview3
08.05.ANI PHARMACEUTICALS INC - 8-K, Current Report1
05.05.ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards?2
23.04.Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue2
21.04.Truist raises ANI Pharmaceuticals target to $65, maintains hold9
12.04.Deep Dive Into ANI Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)3
09.04.ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET3
07.04.Tariff Woes? Play Safe With 4 Low-Beta Stocks: ANIP, EXE, AVA & CTGO1
Weiter >>
74 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1